These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 18038684)
1. What is psychocutaneous medicine? Silverberg NB Cutis; 2007 Oct; 80(4):273. PubMed ID: 18038684 [No Abstract] [Full Text] [Related]
2. A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we? Gee SN; Zakhary L; Keuthen N; Kroshinsky D; Kimball AB J Am Acad Dermatol; 2013 Jan; 68(1):47-52. PubMed ID: 22954748 [TBL] [Abstract][Full Text] [Related]
4. A study of service provision in psychocutaneous medicine. Lowry CL; Shah R; Fleming C; Taylor R; Bewley A Clin Exp Dermatol; 2014 Jan; 39(1):13-8. PubMed ID: 24341475 [TBL] [Abstract][Full Text] [Related]
5. Use of psychotropic drugs in dermatology: unique perspectives of a dermatologist and a psychiatrist. Park KK; Koo J Clin Dermatol; 2013; 31(1):92-100. PubMed ID: 23245980 [TBL] [Abstract][Full Text] [Related]
6. [Dermatology and psychotropic drugs]. Paduart O; Heenen M Ann Dermatol Venereol; 1997; 124(12):878-81. PubMed ID: 9732766 [No Abstract] [Full Text] [Related]
8. The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study. Jafferany M; Vander Stoep A; Dumitrescu A; Hornung RL Int J Dermatol; 2010 Jul; 49(7):784-9. PubMed ID: 20618498 [TBL] [Abstract][Full Text] [Related]
9. Darkness visible: psychocutaneous disease. Elpern DJ South Med J; 2010 Dec; 103(12):1196. PubMed ID: 20978461 [No Abstract] [Full Text] [Related]
10. Psychopharmacology in dermatology. Lee CS; Accordino R; Howard J; Koo J Dermatol Ther; 2008; 21(1):69-82. PubMed ID: 18318888 [TBL] [Abstract][Full Text] [Related]
11. Psychodermatology services guidance: the report of the British Association of Dermatologists' Psychodermatology Working Party. Bewley A; Affleck A; Bundy C; Higgins E; McBride S Br J Dermatol; 2013 Jun; 168(6):1149-50. PubMed ID: 23738635 [No Abstract] [Full Text] [Related]
13. How to recognize and approach psychiatric and psychosocial impairments in the pediatric dermatology patient with a primary dermatologic disease. Andrade G; Castelo-Soccio L Pediatr Dermatol; 2019 Sep; 36(5):759-763. PubMed ID: 31298424 [TBL] [Abstract][Full Text] [Related]
14. Psychopharmacologic therapies in dermatology: an update. Lee CS; Koo J Dermatol Clin; 2005 Oct; 23(4):735-44. PubMed ID: 16112451 [TBL] [Abstract][Full Text] [Related]